Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Innovative Institute of Chinese Medicine and Pharmacy
Qingqing Liu has not added Biography.
If you are Qingqing Liu and would like to personalize this page please email our Author Liaison for assistance.
Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo.
Molecular pharmacology Nov, 2019 | Pubmed ID: 31462456
Targeting Engineered Nanoparticles for Breast Cancer Therapy.
Pharmaceutics Nov, 2021 | Pubmed ID: 34834243
Anti-migratory Properties of Cryoprotective Isoliquiritigenin-zein Phosphatidylcholine Nanoparticles Prevent Triple-negative Breast Cancer through PI3K-mTOR and MMP2/9 Pathways.
Current medicinal chemistry Nov, 2023 | Pubmed ID: 37936460
Chengdu University of Traditional Chinese Medicine
Zhihao Sun1,2,
Wenqiao An2,
Taiping He2,
Qingqing Liu2,
Ziming Wang2,
Pengmei Guo2,
Sanyin Zhang2,3
1School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine,
2Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine,
3Research Institute of Integrated TCM & Western Medicine, Chengdu University of Traditional Chinese Medicine
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır